参考文献/References:
[1]张利娟,徐志敏,郭婧怡,等.2018年全国血吸虫病疫情通报[J].中国血吸虫病防治杂志,2019,31(6):576-582.[2]吴新华,谢曙英,刘骊,等.鄱阳县新报告晚期日本血吸虫病的时空分布特征分析[J].中国人兽共患病学报,2021,37(8):767-772.[3]冯云,张键锋,杭德荣,等.2015-2019年江苏省国家血吸虫病监测点疫情分析[J].热带病与寄生虫学,2021,19(3):139-142.[4]沈双,罗军涛,叶建平.血吸虫病肝纤维化过程中Beclin1调节线粒体功能的初步研究[J].中国寄生虫学与寄生虫病杂志,2020,38(1):41-46.[5]汪天平.迈向消除血吸虫病阶段的防控策略与思考[J].中国血吸虫病防治杂志,2019,31(4):358-361.[6]Masi B,Perles-Barbacaru TA,Bernard M,et al.Clinical and Preclinical Imaging of Hepatosplenic Schistosomiasis[J].Trends Parasitol,2020,36(2):206-226.[7]阮吟,石彦,宁艳,等.常规超声BI-RADS分类结合实时剪切波弹性成像对三阴性乳腺癌的诊断价值[J].蚌埠医学院学报,2020,45(5):630-633.[8]黄仲奎,龙莉玲.慢性肝病与肝癌MSCT及MRI诊断[M].北京:人民卫生出版社,2012:44.[9]谢曙英,张晶,郑彬,等.《血吸虫病诊断标准》(WS261-2006)的实施评价[J].中国寄生虫学与寄生虫病杂志,2019,37(6):699-702,708.[10]邓瑶,汪伟,钱熠礼,等.中国8种寄生虫病期刊发展现状及面临的机遇和挑战[J].预防医学情报杂志,2021,37(7):1024-1030.[11]叶莉,吴晨颖,宋斌.血吸虫病性肝硬化患者腹部CT表现和CT定量参数特征观察[J].实用肝脏病杂志,2021,24(5):645-648.[12]周丽云,吴一鸣,章丽芳.晚期血吸虫病肝纤维化患者血清维生素D表达水平及与肝纤维化进展关系[J].中国血吸虫病防治杂志,2020,32(3):92-95.[13]Amoah AS,Hoekstra PT,Casacuberta-Partal M,et al.Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis[J].Lancet Infect Dis,2020,20(7):e165-e172.[14]吴辉.NK细胞、HA和Ⅳ-C水平与慢性丙肝患者肝纤维化的诊断效能[J].实验与检验医学,2021,39(3):673-675,690.[15]李广平,张红心,张蕾,等.透明质酸、Ⅳ型胶原、APRI及纤维蛋白原-4对乙型肝炎后肝纤维化的诊断价值[J].临床和实验医学杂志,2021,20(13):1385-1388.[16]李洁,杨晓青,齐素艳,等.二维实时剪切波弹性成像诊断慢性肝病肝纤维化各分期的价值[J].河北医科大学学报,2021,42(7):832-836.[17]孟晓贺,祁艳征.实时剪切波弹性成像在乳腺原位癌诊断中的应用价值[J].河南医学研究,2021,30(19):3602-3604.[18]陈丁山,刘明辉.实时剪切波弹性成像诊断血吸虫病肝纤维化[J].中国介入影像与治疗学,2019,16(1):36-40.[19]叶桂林,黄河,凌文武,等.实时二维剪切波弹性成像诊断自身免疫性肝病患者肝纤维化程度[J]. 中国医学影像技术,2021,37(3):401-405.[20]卞锦花,周琦,姜珏,等.实时二维定量剪切波弹性成像对肝纤维化程度的评估价值研究[J].河北医学,2019,25(2):186-189.
相似文献/References:
[1]王艳欣,孟庆华,朱跃科.非侵入性检查方法评价肝纤维化的研究进展[J].医学信息,2018,31(03):40.[doi:10.3969/j.issn.1006-1959.2018.03.014]
WANG Yan-xin,MENG Qing-hua,ZHU Yue-ke.Progress in Evaluation of Liver Fibrosis by Non-invasive Methods[J].Journal of Medical Information,2018,31(18):40.[doi:10.3969/j.issn.1006-1959.2018.03.014]
[2]李顶春,李 武.Wnt信号通路与肝纤维化[J].医学信息,2018,31(09):4.[doi:10.3969/j.issn.1006-1959.2018.09.002]
LI Ding-chun,LI Wu.Wnt Signaling Pathway and Hepatic Fibrosis[J].Journal of Medical Information,2018,31(18):4.[doi:10.3969/j.issn.1006-1959.2018.09.002]
[3]艾迎春,迟男男,杜景峰,等.芪参二莲汤对肝纤维化大鼠基质金属蛋白酶-1及
抑制因子的影响[J].医学信息,2018,31(15):140.[doi:10.3969/j.issn.1006-1959.2018.15.045]
AI Ying-chun,CHI Nan-nan,DU Jing-feng,et al.Effects of Qishenerlian Decoction on Matrix Metalloproteinase-1 and Its Inhibitory Factors in Rats with Hepatic Fibrosis[J].Journal of Medical Information,2018,31(18):140.[doi:10.3969/j.issn.1006-1959.2018.15.045]
[4]董 朴,蔡福景,张 东,等.胆维他片对肝纤维化大鼠肝中抗氧化体系的影响[J].医学信息,2019,32(18):138.[doi:10.3969/j.issn.1006-1959.2019.18.046]
DONG Pu,CAI Fu-jing,ZHANG Dong,et al.Effect of Danweiita Tablet on Antioxidant System in Liver of Rats with Hepatic Fibrosis[J].Journal of Medical Information,2019,32(18):138.[doi:10.3969/j.issn.1006-1959.2019.18.046]
[5]林思萍,龚先琼.中药单体调控TGF-β1/Smads信号通路抗纤维化的研究[J].医学信息,2019,32(21):30.[doi:10.3969/j.issn.1006-1959.2019.21.011]
LIN Si-ping,GONG Xian-qiong.Study on Anti-Fibrosis of TGF-β1/Smads Signaling Pathway Regulated by Chinese Medicine Monomer[J].Journal of Medical Information,2019,32(18):30.[doi:10.3969/j.issn.1006-1959.2019.21.011]
[6]张小雨,严 艳.自身免疫性肝炎合并自身免疫性疾病的特征研究[J].医学信息,2020,33(02):89.[doi:10.3969/j.issn.1006-1959.2020.02.024]
ZHANG Xiao-yu,YAN Yan.Study on the Characteristics of Autoimmune Hepatitis Combined with Autoimmune Diseases[J].Journal of Medical Information,2020,33(18):89.[doi:10.3969/j.issn.1006-1959.2020.02.024]
[7]郭 冶,卢凤美,刘东璞.肝纤维化发病机制及大黄酸对肝纤维化的作用[J].医学信息,2020,33(12):27.[doi:10.3969/j.issn.1006-1959.2020.12.010]
GUO Ye,LU Feng-mei,LIU Dong-pu.The Pathogenesis of Hepatic Fibrosis and the Effect of Rhein on Hepatic Fibrosis[J].Journal of Medical Information,2020,33(18):27.[doi:10.3969/j.issn.1006-1959.2020.12.010]
[8]徐勇平.舒肝宁注射液治疗晚期血吸虫病肝纤维化的效果及其对血清指标的影响[J].医学信息,2020,33(24):151.[doi:10.3969/j.issn.1006-1959.2020.24.043]
XU Yong-ping.Shuganning Injection in the Treatment of Advanced Schistosomiasis Liver Fibrosis and Its Influence on Serum Indexes[J].Journal of Medical Information,2020,33(18):151.[doi:10.3969/j.issn.1006-1959.2020.24.043]
[9]叶 亮,赵永忠.FIB-4、APRI及肝纤维指标对乙型肝炎肝硬化的诊断价值[J].医学信息,2021,34(05):85.[doi:10.3969/j.issn.1006-1959.2021.05.024]
YE Liang,ZHAO Yong-zhong.The Diagnostic Value of FIB-4,APRI and Liver Fiber Indexes in Hepatitis B Liver Cirrhosis[J].Journal of Medical Information,2021,34(18):85.[doi:10.3969/j.issn.1006-1959.2021.05.024]
[10]黄丽玲,吴春城,梁惠卿,等.血清标志物壳多糖酶3样蛋白1评价肝纤维化的研究[J].医学信息,2021,34(10):32.[doi:10.3969/j.issn.1006-1959.2021.10.009]
HUANG Li-ling,WU Chun-cheng,LIANG Hui-qing,et al.Serum Marker Chitinase 3-like Protein 1 in the Evaluation of Liver Fibrosis[J].Journal of Medical Information,2021,34(18):32.[doi:10.3969/j.issn.1006-1959.2021.10.009]